1

2
Bryant Judi, Buckman Brad, Islam Imadul, Mohan Raju, Morrissey Michael, Wei Guo Ping, Xu Wei, Yuan Shendong: 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists. Schering Aktiengesellschaft, Bryant Judi, Buckman Brad, Islam Imadul, Mohan Raju, Morrissey Michael, Wei Guo Ping, Xu Wei, Yuan Shendong, HERMENAU Ronald S, June 24, 2004: WO/2004/052366 (10 worldwide citation)

Compounds of formula (I), where m, n, R1, R2, R3, R4 and R6 are described herein, are useful as inhibitors of platelet adenosine diphosphate. Pharmaceutical compositions containing these compounds, methods of using these compounds as antithrombotic agents and processes for synthesizing these compoun ...


3

4
BUCKMAN BRAD O, EMAYAN KUMAR, ISLAM IMADUL, MAY KAREN, BRYANT JUDI, MOHAN RAJU, WEST CHRISTOPHER L, YUAN SHENDONG: [fr] Dérivés de lacid phosphonic comme inhibiteurs de Plasma Carboxypeptidase B, [de] Phosphonsäure Derivaten als Plasma Carboxypeptidase B Inhibitoren, [en] Phosphonic acid as Plasma Carboxypeptidase B Inhibitors. BAYER SCHERING PHARMA, July 7, 2010: EP2204373-A1

[en] Compounds of the following formula (II), for example: wherein R 1 , R 2 , R 3 , and R 4 are described herein, are useful as inhibitors of plasma carboxypeptidase B. Pharmaceutical compositions containing these compounds, methods of using these compounds as antithrombotic agents and processes fo ...


5

6

7
Bryant Judi, Buckman Brad, Islam Imadul, Mohan Raju, Morrissey Michael, Wei Guo Ping, Xu Wei, Yuan Shendong: Composes de 2-aminocarbonyl-quinoline utilises en tant quantagonistes du recepteur de ladenosine diphosphate des plaquettes, 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists. Schering Aktiengesellschaft, Bayer Schering Pharma Aktiengesellschaft, Marks & Clerk, May 31, 2011: CA2507657

Compounds of formula (I), where m, n, R1, R2, R3, R4 and R6 are described herein, are useful as inhibitors of platelet adenosine diphosphate. Pharmaceutical compositions containing these compounds, methods of using these compounds as antithrombotic agents and processes for synthesizing these compoun ...


8

9
Buckman Brad O, Emayan Kumar, Islam Imadul, May Karen, Bryant Judi, Mohan Raju, West Christopher, Yuan Shendong: Plasma carboxypeptidase b inhibitors. Schering, January 19, 2005: EP1497300-A2

Compounds of the following formula (I), for example: (1), wherein R, R, R, and R are described herein, are useful as inhibitors of plasma carboxypeptidase B. Pharmaceutical compositions containing these compounds, methods of using these compounds as antithrombotic agents and processes for synthesizi ...


10
Bryant Judi A, Buckman Brad O, Islam Imadul, Mohan Raju, Morrissey Michael M, Wei Guo Ping, Xu Wei, Yuan Shendong: (naphthaline) Platelet adenosine diphosphate receptor antagonists. Schering, April 28, 2004: EP1412349-A2

Compounds of the following formula (I): where a, b, R, R, R, R and R are described herein, are useful as inhibitors of platelet adenosine diphosphate. Pharmaceutical compositions containing these compounds, methods of using these compounds as antithrombotic agents and processes for synthesizing thes ...